Ocular Therapeut
(OCUL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2013 | 12-2012 | |
| Cash Flows From Operating Activities | ||
| Net Income | -6,290 | -14,090 |
| Depreciation Amortization | 187 | 400 |
| Accounts receivable | 27 | N/A |
| Accounts payable and accrued liabilities | -96 | N/A |
| Other Working Capital | -476 | 720 |
| Other Operating Activity | 310 | 390 |
| Operating Cash Flow | $-6,338 | $-12,580 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -72 | -200 |
| Other Investing Activity | 0 | 4,010 |
| Investing Cash Flow | $-72 | $3,810 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 8,494 | N/A |
| Debt Repayment | -910 | N/A |
| Common Stock Issued | 2 | N/A |
| Other Financing Activity | 0 | 27,290 |
| Financing Cash Flow | $7,586 | $27,290 |
| Beginning Cash Position | 23,854 | 5,330 |
| End Cash Position | 25,030 | 23,850 |
| Net Cash Flow | $1,176 | $18,520 |
| Free Cash Flow | ||
| Operating Cash Flow | -6,338 | -12,580 |
| Capital Expenditure | -72 | N/A |
| Free Cash Flow | -6,410 | -12,580 |